Dr Ashley Bush joins scientific advisory board at Adeona
This article was originally published in Scrip
Adeona Pharmaceuticals, an Ann Arbor, Michigan-based developer of medicines for serious central nervous system diseases, has elected Dr Ashley Bush to its scientific advisory board. He is a National Health and Medical Research Council Australia Fellow and head of the oxidation disorders laboratory for the Mental Health Research Institute, University of Melbourne. Dr Bush has also served as the director of the laboratory for oxidation biology, Massachusetts General Hospital, and associate professor of psychiatry at Harvard Medical School.